Literature DB >> 15108720

Structural studies on the Ebola virus matrix protein VP40 indicate that matrix proteins of enveloped RNA viruses are analogues but not homologues.

Joanna Timmins1, Rob W H Ruigrok, Winfried Weissenhorn.   

Abstract

Matrix proteins are the driving force of assembly of enveloped viruses. Their main function is to interact with and polymerize at cellular membranes and link other viral components to the matrix-membrane complex resulting in individual particle shapes and ensuring the integrity of the viral particle. Although matrix proteins of different virus families show functional analogy, they share no sequence or structural homology, Their diversity is also evident in that they use a variety of late domain motifs to commit the cellular vacuolar protein sorting machinery to virus budding. Here, we discuss the structural and functional aspects of teh filovirus matrix protein VP40 and compare them to other known matrix protein structures from vesicular stomatitis virus adn retroviral matrix protein.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15108720      PMCID: PMC7110346          DOI: 10.1016/j.femsle.2004.03.002

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


Overview of general matrix protein functions

Enveloped RNA viruses from the families of Filoviridae, Paramyxoviridae, Rhabdoviridae and Bornaviridae (constituting the order Mononegavirales), Orthomyxoviridae and Retroviridae are a morphologically diverse group of viruses. The viral shape is determined by the matrix protein and the nucleocapsid that are responsible for producing spherical, rod-shaped, bullet-shaped or bacilliform particles. Viral matrix proteins generally constitute a major structural protein of the viral particle and are located underneath the viral membrane. During the assembly process in a host cell, matrix proteins self-assemble into higher-order oligomers and/or polymerise at cellular membranes [1,2]. They display a high tendency to aggregate in vitro, which may reflect their ability to self-assemble in vivo. Matrix proteins interact with membranes and evidence suggests that they provide a link between the cytoplasmic tails of the glycoproteins and the nucleocapsids that contain the RNA genome within the viral particle [2]. Although in some cases matrix protein expression in eukaryotic cells is sufficient to induce virus-like particles (VLPs) [3-5], the structural requirements for such ordered membrane-associated polymerisation reactions are not well understood and often depend on other viral components such as the glycoprotein [2]. In addition, cellular factors modulating membrane structures might play a role. Consequently, no virus-like particles have yet been produced from soluble matrix proteins and artificial lipid bilayers in vitro. In contrast to segmented and non-segmented negative strand viruses, retroviral matrix proteins are initially part of the Gag poly-protein. Expression of Gag is largely sufficient to perform virus assembly and budding at the plasma membrane which leads to the release of virus-like particles (VLPs). In immature viral particles, proteolytic processing generates several distinct protein products, including MA (matrix protein), CA (capsid protein) and NC (nucleocapsid protein) thus producing mature infectious virions. Like the matrix protein from negative strand RNA viruses MA is associated with the viral membrane and thus performs essentially the same structural function [6].

Lipid rafts are microdomains for enveloped virus assembly

Lipid rafts are enriched in cholesterol and sphingolipids that can selectively incorporate or exclude proteins and have been first implicated in influenza virus budding [7]. Subsequent studies found the same principle for measles virus, HIV and Ebola virus. These studies show that lipid rafts concentrate glycoproteins and matrix proteins thus establishing platforms for efficient assembly and budding [2].

The cellular machinery for budding

The first evidence for the involvement of specific Gag domains in viral budding came from the work of Göttlinger and colleagues who reported that a deletion of the C-terminal region of HIV Gag (p6 protein) caused a significant defect in virus particle release [8]. Electron microscopy studies revealed that these particles failed to pinch off the plasma membrane. Subsequent studies then identified a highly conserved Pro-Thr-Ala-Pro sequence motif, termed late domain, as playing a crucial role in viral budding [9]. Up to date, several classes of viral late domains have been described, namely P(T/S)AP, YXXL LXXLF and PPXY. They are present alone or in different combinations in the matrix proteins of negative-strand RNA viruses and in the Gag proteins of retroviruses. In several cases, viral late domains have been shown to be functionally interchangeable, can be positioned at various locations and can act in trans[10]. Recent studies show that the late domains serve as entry points into the vacuolar protein sorting (Vps) pathway and connect matrix proteins or Gag to cellular factors. The Vps machinery was first described in yeast and implicated in membrane protein trafficking from the Golgi and plasma membrane via the endosomal system to the lysosome for degradation (for review, see [11]). Mutation of any of the 17 different yeast Vps proteins leads to the formation of enlarged endosomal membrane compartments that cannot mature into multi vesicular bodies (MVB; class E compartment). Most of the class E Vps proteins exist as soluble proteins or small subcomplexes that are sequentially recruited to the site of MVB formation. Initial recognition of the cargo involves class E proteins Hrs (Vps27p), Stam, Eps15 (Ede1p) and clathrin. This leads to the recruitment of ESCRT-1 (endosome-associated complexes required for transport), composed of Vps23p, Vps28p and Vps37p to the endosomal membrane where it recognizes ubiquitinated cargo. ESCRT-I cargo recognition then induces the formation of ESCRT-II (Vps22p, Vps25p and Vps36p) and that in turn activates the assembly of ESCRT-III multi-protein complexes. Finally, another class E Vps protein, Vps4 an AAA-type ATPase, has been implicated in the disassembly of ESCRT-III a necessary step for MVB formation (reviewed by Katzmann et al. [11]). Although the mammalian system is more complex the framework is similar. Most of the components have now been described and their interactions have been mapped [12,13]. There are two human class E Vps proteins identified that recognize late domains, namely tsg101 (via P(T/S)AP), which is part of ESCRT-I and AIP-1/ALIX (via LXXLF and YXXL) which in turn interacts with Tsg101 and CHMP4 proteins (ESCRT-III), thus providing a link between ESCRT-I and ESCRT-III in retroviral budding [12,13]. It is now recognized that late domain interactions with cellular factors most likely recruit the whole Vps machinery to the site of budding. The PPXY motif, the fourth identified late domain has been found in some retroviruses, in rhabdoviruses and filoviruses ([10] and references therein). The PPXY motif mediates interactions with proteins that contain WW domains, such as Nedd4 family ubiquitin ligases (E3 enzyme), which are part of an enzymatic cascade in which single ubiquitin moieties are transferred to lysine residues on the protein substrate. Monoubiquitination of matrix proteins is consistent with recent findings that show that ubiquitin plays a role in retrovirus budding [14,15] and that Ebola virus VP40 can be ubiquitinated in vitro [16]. Ubiquitination may thus help to recruit the class E Vps components in a similar way as sorting of plasma membrane receptors requires monoubiquitination [11]. In addition, Nedd4, which can be also found in lipid rafts [17], has been linked genetically to ESCRT-III in yeast [18]. Finally, lipids and lipid modifying enzymes, such as endophilins that interact with AIP1/ALIX [19] might play an important role in viral budding [20]. Up to now not all enveloped viruses contain any of the known late domain sequences which could serve as entry points into the Vps machinery; however it is likely that they might yet use other short sequence elements which facilitate Vps recruitment. In addition this function may not reside within the matrix protein.

Structures of viral matrix proteins

To date there is still limited structural information on viral matrix proteins as only four different matrix protein structures have been solved, including VP40 from Ebola virus, M from VSV, a fragment of M1 from influenza virus and a number of retroviral matrix proteins.

Ebola virus matrix protein VP40

The Ebola virus matrix protein VP40 is an elongated, two-domain monomeric assembly, composed of two structurally related β-sandwich domains, which are connected by a flexible linker (Fig. 1(a)). Indeed the unique fold of both domains suggests that the two domains probably arose from a common ancestor by gene duplication [21]. Early work showed that this conformation of VP40 is metastable, which allows an easy transition into oligomeric ring-like structures in vitro [22,23]. The ring-structures are either octamers or hexamers [24] (Figs. 1(b) and (c)). In both cases, the N-terminal domain of VP40 constitutes the oligomerisation domain, which forms an anti-parallel dimer and is the building block for oligomerisation [23,25]. The C-terminal domains are flexibly attached to the rings and mediate membrane association in vitro and in vivo [5,22,23] (Figs. 1(b) and (c)).
1

Ribbon diagrams and an electron microscopy reconstruction image of structures showing different conformations of the Ebola virus matrix protein VP40. (a) Monomeric VP40 is composed of two structurally related β sandwich domains. The N-terminal domain (N-terminal residue 44) mediates oligiomerisation and the C-terminal domain (C-terminal end residue 321) is responsible for membrane association. (b) The N-terminal domain of VP40 forms octamers by binding specific single-stranded RNA having the sequence 5-UGA-3′ at the dimer–dimer interface. The RNA is shown as all atom model. The N- (residue 69) and C-terminal (residue 190) ends are indicated. Note that the C-terminal ends connect to the C-terminal domain, which is missing in the structure. This is also indicated by the flexible attachment of two C-terminal domains (white). (c) Full-length VP40 can be also activated to form hexamers, which is mediated by the N-terminal domain. The electron microscopy reconstruction shows that two N-terminal domains assemble to create a ring-structure having threefold-symmetry. Like in the octamer structure the C-terminal domains are flexibly attached to the ring structure as indicated by two C-terminal domains and by the electron microscopy reconstructions [23].

Ribbon diagrams and an electron microscopy reconstruction image of structures showing different conformations of the Ebola virus matrix protein VP40. (a) Monomeric VP40 is composed of two structurally related β sandwich domains. The N-terminal domain (N-terminal residue 44) mediates oligiomerisation and the C-terminal domain (C-terminal end residue 321) is responsible for membrane association. (b) The N-terminal domain of VP40 forms octamers by binding specific single-stranded RNA having the sequence 5-UGA-3′ at the dimer–dimer interface. The RNA is shown as all atom model. The N- (residue 69) and C-terminal (residue 190) ends are indicated. Note that the C-terminal ends connect to the C-terminal domain, which is missing in the structure. This is also indicated by the flexible attachment of two C-terminal domains (white). (c) Full-length VP40 can be also activated to form hexamers, which is mediated by the N-terminal domain. The electron microscopy reconstruction shows that two N-terminal domains assemble to create a ring-structure having threefold-symmetry. Like in the octamer structure the C-terminal domains are flexibly attached to the ring structure as indicated by two C-terminal domains and by the electron microscopy reconstructions [23]. The octamer was found to bind single stranded RNA at the dimer–dimer interface having the sequence 5′-UGA-3′ (Fig. 1(b)). RNA binding creates a new dimer–dimer interface and its binding stabilizes the protein–protein interaction generating the octamers [25]. Based on the crystal structure of the octamer, the complete N-terminal segment from residues 1 to 68 has to unfold in order to create the new ssRNA-binding interface. Interestingly recent studies suggest that the SDS resistant octamer is present in Ebola VLPs and in virus particles [26] in contrast to our previous finding which confirmed the presence of RNA containing octamers only in infected cells but not in virus particles [25]. A role for the ring structures in assembly and budding is also evident from the fact that only oligomeric VP40 interacted with WW3 from human Nedd4 in vitro via its N-terminal PPXY motif [27], an interaction which is important in vivo [28]. A number of studies also showed the importance of the PTAP motif present at the N-terminus for budding [29,30]. This motif binds to the UEV domain of Tsg101 independent of its oligomeric state. Thus, monomeric VP40 recruits Tsg101 to the site of budding [26,27], which in turn might recruit the complete Vps machinery for efficient budding as demonstrated in case of HIV-1 [12]. The late domain sequences are not present in the crystal structures of VP40 as they had been removed by proteolysis for efficient crystallisation purposes. The structural studies of Ebola virus VP40 have now firmly established three conformations of Ebola virus VP40, although their role in assembly and budding or additional functions during the life cycle of Ebola virus is far from clear. It is, however, an interesting example of evolution that packs different functional aspects into one relatively small protein probably due to the limiting size of the viral genome.

Vesicular stomatitis virus M

The structure of the matrix protein form vesicular stomatitis virus consists of an N-terminal part composed of a five-stranded anti-parallel β-sheet packed against two β-helices and a small C-terminal part made up by a two-stranded β-sheet and an α-helix, which connects to the N-terminal region via a long linker (Fig. 2(a)) [31]. As with Ebola VP40, the vesiculovirus matrix protein displays a new fold. No defined oligomeric structures have been described for VSV M, which, however, polymerises in vitro [32].
2

Ribbon diagrams of other known matrix protein structures. The N- and C-terminal ends are indicated. Note that the folds of Ebola virus VP40 (Fig. 1(a)) and the structures shown here are all different. (a) Crystal structure of the M protein from VSV. (b) Crystal structure of the influenza virus M1 N-terminal domain. The putative position of the C-terminal domain is indicated by the square. (c) Crystal structure of the matrix protein MA from HIV-1. The arrow indicates the suggested membrane-binding surface.

Ribbon diagrams of other known matrix protein structures. The N- and C-terminal ends are indicated. Note that the folds of Ebola virus VP40 (Fig. 1(a)) and the structures shown here are all different. (a) Crystal structure of the M protein from VSV. (b) Crystal structure of the influenza virus M1 N-terminal domain. The putative position of the C-terminal domain is indicated by the square. (c) Crystal structure of the matrix protein MA from HIV-1. The arrow indicates the suggested membrane-binding surface. For structure determination, VSV M was purified from virus and solubilized by thermolysin cleavage, which removes residues 1–49 and 121–122/124, thus preventing polymerisation (Fig. 2(a)). Full length VSV M has a high tendency to self-associate into large multimers [33], which is sensitive to salt treatment in vitro [34]. Expression of M protein induces the formation and budding of vesicles, which is consistent with its membrane association and polymerisation activities. These particles, however, do not show the characteristic bullet-shaped structure of rhabdoviruses indicating that other viral components such as nucleocapsids are responsible for the distinct morphology of VSV [3]. The structure can be considered to represent the membrane-activated form that, however, no longer binds artificial membranes due to proteolytic removal of residues 121–122/124 [31]. It is conceivable that VSV M adopts a different conformation before activation, as cellular expression does not per se lead to polymerisation and membrane binding but produces mostly cytoplasmic M [33,35]. This putative other conformation(s) might then be also responsible for secondary functions of VSV M such as, inhibition of transcription and nucleocytoplasmic transport, nuclear localisation and cell rounding due to the induction of apoptosis [36-40]. VSV M has been also implicated in nucleocapsid condensation [41], which may be similar to the function of Ebola virus VP24 in nucleocapsid formation [42]. In addition, VSV M contains the late domain motifs PPPY and PSAP within the N-terminal 40 residues ([10] and references therein), which are missing in the crystal structure. The PPPY motif was shown to interact with mouse Nedd4 and proteasome inhibitors reduced virus titers implicating ubiquitin in virus budding [43]. The question remains whether any conformational diversity of VSV M might contribute to its different functions.

Influenza virus M1

The structure of the N-terminal domain of Influenza virus M1 protein has been solved at pH 4.0 [44] and at neutral pH [45]. Both structures are identical and consist of two four-helical bundle subdomains that pack against each other through a hydrophobic interface (Fig. 2(b)). The fold is again different from other known matrix protein structures. One side of the N-terminal domain of M1 is strictly positively charged while the opposite one exhibits an all-negative charge [45]. Proteolysis experiments suggest that the C-terminal domain is attached through a flexible linker. Established functions of M1 are membrane association and polymerisation of the N-terminal domain and RNP binding of the C-terminal domain [46]. The N-terminal domain also contains a stretch of basic residues, which have been implicated in nuclear localisation of M1 and export processes [47,48]. Overexpression of M1 in eukaryotic cells leads to the formation of intracellular tubular structures and the release of virus-like particles (VLPs), indicating that M1 contains all the information for assembly and budding [49]. VLP formation, however, is also enhanced by co-expression of HA which might augment M1 membrane association [49,50]. Although M1 has a high tendency to polymerise in vitro, its conformation upon cytoplasmic expression must be postulated to be monomeric as cytoplasmic and nuclear M1 pools have been reported in addition to membrane associated M1 [51,52]. The activation process and the structural changes that lead to specific M1 polymerisation at membranes in vivo have not yet been described. M1 also exerts a number of additional functions, such as transport of RNP cores out of the nucleus [52]. No functional late domain sequences have yet been described for M1. As the complexity of the MVB machinery provides multiple possible entry points to contribute to its activation for budding processes, it is, however, unlikely that influenza uses another cellular machinery for budding.

HIV-1 matrix MA

The crystal structure of the matrix protein from HIV-1 and SIV folds into an arrangement of five α-helices and a three-stranded mixed β-sheet, a fold, which is unique to retroviral matrix proteins [53,54]. Helices 1–3 pack about a central helix (4) forming a compact globular domain that is capped by the β-sheet, while helix 5 extends away from the core (Fig. 2(c)). HIV-1 MA can form a trimer in solution and can polymerise into a crystalline lattice. The trimers have been suggested to form the building block for the mature MA shell. There, the individual trimers present a largely basic surface on one side that was proposed to interact with the inner membrane of the virus. Such an arrangement would pose the myristoylated N-terminal residue that is essential for membrane targeting close to the membrane and the C-terminal helix 5 would point towards the interior of the viral particle [53,54]. In addition to forming a protein shell underneath the viral membrane, MA is also part of the pre-integration reverse transcriptase complex that travels towards the nucleus along microtubules using the kinesin KIF-4 upon viral entry [55] and seems to be required for nuclear import [56]. Although the sequences of retrovirus matrix proteins differ significantly, the known structures of retroviral matrix proteins (SIV; bovine leukaemia virus, HTLV-II; Mason–Pfizer monkey virus; equine infectious anemia virus) exhibit the same common fold reflecting their evolutionary relationship [57]. Retroviral Gag proteins contain either one or two late domain sequences at different locations. HIV-1 Gag has two essential sequence motifs PTAP and LXXLF within the C-terminal fragment p6 while PPPY and PTAP motifs locate to the C-terminus of MA from HTLV-I [58].

Evolutionary sequence conservation

Sequence analysis between members of Filoviridae (Ebola and Marburg virus VP40), Paramyxoviridae (subfamily Paramyxovirinae: Sendai virus, SV5, measles virus; and subfamily pneumovirinae, human respiratory syncytial virus), Rhabdoviridae (VSV; rabies virus) and Bornaviridae (Borna disease virus) reveals no significant sequence identity (ranging from 2% to 7%). The same is true when comparing matrix proteins from the Mononegavirales with M1 from influenza virus and MA from retroviruses, which also underlines their observed structural diversity.

Conclusions

In summary, the known matrix protein structures indicate no structural homology between non-segmented negative strand RNA viruses such as Filoviridae (Ebola virus) and Rhabdoviridae (VSV) and segmented negative strand RNA viruses such as Orthomyxoviridae (influenza virus) as well as Retroviridae (HIV), although they share common functions. A minimal structural conservation is the presence of late domain sequences that mediate interaction with the class E Vps machinery for budding, although this still has to be shown in case of influenza virus M1. In addition, there is no striking common motif evident for membrane interaction, a common functional property of all viral matrix proteins. This is in contrast to the functional and structural conservation of the fusion protein subunit of the glycoproteins derived from retroviruses (HIV-1; HTLV-I), filoviruses (Ebola), paramyxoviruses (SV5) and orthomyxoviruses (influenza virus) which show striking similarities [59]. They all fold into trimeric rod-like structures composed of a central triple-stranded coiled coil and an outer helical or non-helical layer. This arrangement places the fusion peptide and the transmembrane region at one end of the rod, which facilitates fusion of viral and cellular membranes during viral entry [60]. The conserved function and conformation of the fusion proteins may therefore be based on a common ancestral viral fusion protein [61]. The structural dissimilarity of matrix proteins might indicate two different scenarios: (i) Matrix proteins from related viruses have evolved from a common ancestor and have changed over time completely as they acquired new functions that helped to adapt to the hosts. Such dramatic changes could have been supported by their high mutation rate [62]. (ii) Secondly, matrix proteins have nothing in common with each other as they have been acquired independently during evolution. Although there is no doubt that matrix proteins are the major driving forces for assembly and budding there is some evidence that matrix protein-free viruses might have existed as matrix-less measles virus, VSV and rabies virus show infectivity, albeit severely impaired [63-65]. In addition, other enveloped viruses have solved their envelope acquirement differently, namely flaviviruses and alphaviruses use their glycoprotein to form a protein shell on the outside of the lipid bilayer envelope [66]. A third class of enveloped viruses, the corona virus uses an integral membrane protein that might function as a matrix protein [67]. In conclusion, different matrix protein conformations and/or their diverse oligomeric states or polymerisation features are most likely to contribute to the morphological differences between viral families.
  66 in total

1.  Structural characterization and membrane binding properties of the matrix protein VP40 of Ebola virus.

Authors:  R W Ruigrok; G Schoehn; A Dessen; E Forest; V Volchkov; O Dolnik; H D Klenk; W Weissenhorn
Journal:  J Mol Biol       Date:  2000-06-30       Impact factor: 5.469

2.  Influenza virus matrix protein is the major driving force in virus budding.

Authors:  P Gómez-Puertas; C Albo; E Pérez-Pastrana; A Vivo; A Portela
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Ubiquitin is part of the retrovirus budding machinery.

Authors:  A Patnaik; V Chau; J W Wills
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

Review 4.  Structural basis for membrane fusion by enveloped viruses.

Authors:  W Weissenhorn; A Dessen; L J Calder; S C Harrison; J J Skehel; D C Wiley
Journal:  Mol Membr Biol       Date:  1999 Jan-Mar       Impact factor: 2.857

5.  Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release.

Authors:  H G Göttlinger; T Dorfman; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

6.  Nucleus-targeting domain of the matrix protein (M1) of influenza virus.

Authors:  Z Ye; D Robinson; R R Wagner
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

7.  Membrane vesiculation function and exocytosis of wild-type and mutant matrix proteins of vesicular stomatitis virus.

Authors:  P A Justice; W Sun; Y Li; Z Ye; P R Grigera; R R Wagner
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

8.  The cell-rounding activity of the vesicular stomatitis virus matrix protein is due to the induction of cell death.

Authors:  Sarah A Kopecky; Douglas S Lyles
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

9.  Visualization of the intracellular behavior of HIV in living cells.

Authors:  David McDonald; Marie A Vodicka; Ginger Lucero; Tatyana M Svitkina; Gary G Borisy; Michael Emerman; Thomas J Hope
Journal:  J Cell Biol       Date:  2002-11-04       Impact factor: 10.539

Review 10.  SARS--beginning to understand a new virus.

Authors:  Konrad Stadler; Vega Masignani; Markus Eickmann; Stephan Becker; Sergio Abrignani; Hans-Dieter Klenk; Rino Rappuoli
Journal:  Nat Rev Microbiol       Date:  2003-12       Impact factor: 60.633

View more
  17 in total

1.  Role of residues 121 to 124 of vesicular stomatitis virus matrix protein in virus assembly and virus-host interaction.

Authors:  John H Connor; Margie O McKenzie; Douglas S Lyles
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

2.  YRKL sequence of influenza virus M1 functions as the L domain motif and interacts with VPS28 and Cdc42.

Authors:  Eric Ka-Wai Hui; Subrata Barman; Dominic Ho-Ping Tang; Bryan France; Debi P Nayak
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

3.  Surface features of a Mononegavirales matrix protein indicate sites of membrane interaction.

Authors:  Victoria A Money; Helen K McPhee; Jackie A Mosely; John M Sanderson; Robert P Yeo
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-26       Impact factor: 11.205

4.  The lack of an inherent membrane targeting signal is responsible for the failure of the matrix (M1) protein of influenza A virus to bud into virus-like particles.

Authors:  Dan Wang; Aaron Harmon; Jing Jin; David H Francis; Jane Christopher-Hennings; Eric Nelson; Ronald C Montelaro; Feng Li
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

Review 5.  Interactions between virus proteins and host cell membranes during the viral life cycle.

Authors:  Rodrigo A Villanueva; Yves Rouillé; Jean Dubuisson
Journal:  Int Rev Cytol       Date:  2005

6.  Crystal structure of the Borna disease virus matrix protein (BDV-M) reveals ssRNA binding properties.

Authors:  Piotr Neumann; Diana Lieber; Sylke Meyer; Philipp Dautel; Andreas Kerth; Ina Kraus; Wolfgang Garten; Milton T Stubbs
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

7.  Vesicular stomatitis virus matrix protein impairs CD1d-mediated antigen presentation through activation of the p38 MAPK pathway.

Authors:  Gourapura J Renukaradhya; Masood A Khan; Daniel Shaji; Randy R Brutkiewicz
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

8.  Vesicular stomatitis virus matrix protein mutations that affect association with host membranes and viral nucleocapsids.

Authors:  Brooke Dancho; Margie O McKenzie; John H Connor; Douglas S Lyles
Journal:  J Biol Chem       Date:  2008-12-16       Impact factor: 5.157

Review 9.  No exit: targeting the budding process to inhibit filovirus replication.

Authors:  Ronald N Harty
Journal:  Antiviral Res       Date:  2008-12-27       Impact factor: 5.970

10.  The Functional Oligomeric State of Tegument Protein GP41 Is Essential for Baculovirus Budded Virion and Occlusion-Derived Virion Assembly.

Authors:  Yimeng Li; Shu Shen; Liangbo Hu; Fei Deng; Just M Vlak; Zhihong Hu; Hualin Wang; Manli Wang
Journal:  J Virol       Date:  2018-05-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.